お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
975219

COVID-19ポイントオブケア (POC) 検査 - 医療機器のパイプライン評価

COVID-19 Point of Care (POC) Tests - Medical Devices Pipeline Assessment, 2020

出版日: | 発行: GlobalData | ページ情報: 英文 491 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.77円
COVID-19ポイントオブケア (POC) 検査 - 医療機器のパイプライン評価
出版日: 2020年12月01日
発行: GlobalData
ページ情報: 英文 491 Pages
納期: 即納可能 即納可能とは
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、COVID-19ポイントオブケア (POC) 検査のパイプライン製品について調査分析し、開発段階別の比較分析に焦点を当てて、パイプライン製品の開発に従事している主要企業、進行中の臨床試験に関する情報なども含めて、体系的な情報を提供しています。

目次

第1章 目次

第2章 イントロダクション

第3章 開発中の製品

  • COVID-19ポイントオブケア (POC) 検査 - パイプライン製品:開発段階別
  • COVID-19ポイントオブケア (POC) 検査 - パイプライン製品:地域別
  • COVID-19ポイントオブケア (POC) 検査 - パイプライン製品:規制経路別
  • COVID-19ポイントオブケア (POC) 検査 - パイプライン製品:承認予定日別
  • COVID-19ポイントオブケア (POC) 検査 - 進行中の臨床試験

第4章 COVID-19ポイントオブケア (POC) 検査 - 開発中のパイプライン製品:企業別

  • COVID-19ポイントオブケア (POC) 検査企業 - パイプライン製品:開発段階別
  • COVID-19ポイントオブケア (POC) 検査 - パイプライン製品:開発段階別

第5章 COVID-19ポイントオブケア (POC) 検査企業と製品の概要

第6章 COVID-19ポイントオブケア (POC) 検査 - 最近の動向

第7章 付録

図表

List of Tables

  • Table 1: COVID 19 point of care (POC) Tests - Pipeline Products by Stage of Development
  • Table 2: COVID 19 point of care (POC) Tests - Pipeline Products by Territory
  • Table 3: COVID 19 point of care (POC) Tests - Pipeline Products by Regulatory Path
  • Table 4: COVID 19 point of care (POC) Tests - Pipeline Products by Estimated Approval Date
  • Table 5: COVID 19 point of care (POC) Tests - Ongoing Clinical Trials
  • Table 6: COVID 19 point of care (POC) Tests Companies - Pipeline Products by Stage of Development
  • Table 7: COVID 19 point of care (POC) Tests - Pipeline Products by Stage of Development
  • Table 8: 20/20 GeneSystems Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 9: CoronaCheck COVID-19 Rapid Antibody Test Kit - OTC - Product Status
  • Table 10: CoronaCheck COVID-19 Rapid Antibody Test Kit - OTC - Product Description
  • Table 11: 3a-Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Table 12: Microbial-Enzyme Screening Test - COVID-19 - Product Status
  • Table 13: Microbial-Enzyme Screening Test - COVID-19 - Product Description
  • Table 14: RT-PCR COVID-19 Test Kit - Product Status
  • Table 15: RT-PCR COVID-19 Test Kit - Product Description
  • Table 16: 3M Co Pipeline Products & Ongoing Clinical Trials Overview
  • Table 17: Rapid COVID-19 Test - Product Status
  • Table 18: Rapid COVID-19 Test - Product Description
  • Table 19: Abbott Laboratories Pipeline Products & Ongoing Clinical Trials Overview
  • Table 20: Panbio COVID-19 IgG/IgM Rapid Test Device - Product Status
  • Table 21: Panbio COVID-19 IgG/IgM Rapid Test Device - Product Description
  • Table 22: Abingdon Health Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 23: AbC-19 Rapid Test - Product Status
  • Table 24: AbC-19 Rapid Test - Product Description
  • Table 25: QwikZyme - Product Status
  • Table 26: QwikZyme - Product Description
  • Table 27: Abnova Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 28: COVID-19 Human IgM/IgG Rapid Test - Product Status
  • Table 29: COVID-19 Human IgM/IgG Rapid Test - Product Description
  • Table 30: Lateral Flow Rapid Test - COVID-19 - Product Status
  • Table 31: Lateral Flow Rapid Test - COVID-19 - Product Description
  • Table 32: Serum Antibody Rapid Test - COVID-19 - Product Status
  • Table 33: Serum Antibody Rapid Test - COVID-19 - Product Description
  • Table 34: Abnova Corp - Ongoing Clinical Trials Overview
  • Table 35: Serum Antibody Rapid Test - COVID-19 - Study Evaluate the Efficacy of Serum Antibody Rapid Test - COVID-19
  • Table 36: Absea Biotechnology Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 37: MEGA Test - SARS-CoV-2 - Product Status
  • Table 38: MEGA Test - SARS-CoV-2 - Product Description
  • Table 39: Absology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 40: Absoludy COVID-19 IgM/IgG Rapid Test - Product Status
  • Table 41: Absoludy COVID-19 IgM/IgG Rapid Test - Product Description
  • Table 42: Academia Sinica Pipeline Products & Ongoing Clinical Trials Overview
  • Table 43: Anti-SARS-CoV-2 Nucleocapsid Protein Human IgM/IgG Rapid Detection Kit - Product Status
  • Table 44: Anti-SARS-CoV-2 Nucleocapsid Protein Human IgM/IgG Rapid Detection Kit - Product Description
  • Table 45: SARS-CoV-2 Nucleocapsid Protein Rapid Detection Kit - Product Status
  • Table 46: SARS-CoV-2 Nucleocapsid Protein Rapid Detection Kit - Product Description
  • Table 47: Accel Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 48: Rapid C2T Total Antibodies (IgG/IgM) Card - Product Status
  • Table 49: Rapid C2T Total Antibodies (IgG/IgM) Card - Product Description
  • Table 50: Accobiotech Sdn Bhd Pipeline Products & Ongoing Clinical Trials Overview

List of Figures

  • Figure 1: COVID 19 point of care (POC) Tests - Pipeline Products by Stage of Development
  • Figure 2: COVID 19 point of care (POC) Tests - Pipeline Products by Territory
  • Figure 3: COVID 19 point of care (POC) Tests - Pipeline Products by Regulatory Path
  • Figure 4: COVID 19 point of care (POC) Tests - Pipeline Products by Estimated Approval Date
  • Figure 5: COVID 19 point of care (POC) Tests - Ongoing Clinical Trials
目次
Product Code: GDME1097EPD

GlobalData's Medical Devices sector report, "COVID 19 point of care (POC) Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the COVID 19 point of care (POC) Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

COVID 19 Point of Care (POC) Tests are used to detect the presence or activity of COVID-19 antigen. This segment includes rapid t/ests and point of care tests for COVID-19.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the COVID 19 point of care (POC) Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of COVID 19 point of care (POC) Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of COVID 19 point of care (POC) Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. COVID 19 point of care (POC) Tests Overview

3. Products under Development

  • 3.1. COVID 19 point of care (POC) Tests - Pipeline Products by Stage of Development
  • 3.2. COVID 19 point of care (POC) Tests - Pipeline Products by Territory
  • 3.3. COVID 19 point of care (POC) Tests - Pipeline Products by Regulatory Path
  • 3.4. COVID 19 point of care (POC) Tests - Pipeline Products by Estimated Approval Date
  • 3.5. COVID 19 point of care (POC) Tests - Ongoing Clinical Trials

4. COVID 19 point of care (POC) Tests - Pipeline Products under Development by Companies

  • 4.1. COVID 19 point of care (POC) Tests Companies - Pipeline Products by Stage of Development
  • 4.2. COVID 19 point of care (POC) Tests - Pipeline Products by Stage of Development

5. COVID 19 point of care (POC) Tests Companies and Product Overview

6. COVID 19 point of care - Recent Developments

7. Appendix

株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.